Loading organizations...
§ Venture Capital · Dover, DE, USA
Venture capital firm building & investing in early-stage life sciences companies, focused on preventing, detecting, and curing disease.
ARCH Venture Partners is a venture capital firm specializing in creating and funding early-stage companies built upon scientific breakthroughs. The firm translates groundbreaking research, predominantly in life sciences, into viable commercial enterprises. It actively cultivates disruptive technologies aimed at solving critical challenges across health and scientific sectors.
Established in 1986 by Steven Lazarus, Clinton Bybee, Keith Crandell, and Robert Nelsen, ARCH Venture Partners formed around the insight that academic scientific discoveries could seed significant new companies. The founders' combined expertise allowed them to bridge the divide between innovative research and market application, fostering emerging ventures from their inception.
ARCH Venture Partners collaborates with scientists and entrepreneurs developing novel technologies poised for profound societal impact. The firm’s enduring vision is to catalyze discoveries leading to disease prevention, detection, and treatment, actively fostering an environment where scientific innovation drives the next generation of healthcare advancements.
ARCH Healthcare Fund has 1 tracked investment across 1 company. The latest tracked deal is $34.8M Debt / Series B in Arbor Pharmaceuticals in November 2010.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 12, 2010 | Arbor Pharmaceuticals | $34.8M Debt / Series B | Signet Healthcare Partners | JW Asset Management |